Scientific Programme 2022

Wednesday 19th January 2022

Moderator: Hans Eiskjaer + one young investigator

(20 min talk and 10 min discussion)

16.00–16.30

The Future of Machine Perfusion in DCD Organ Transplantation

Andres Wallinder.
TBC

16.30–17.00

Development of DCD transplantation in Europe: Hearte

Michiel Erasmus
Groningen

17.00–17.30

Is Two Really Better Than One? Multi-Organ Cardiothoracic transplantation

Clive Lewis
Cambridge

17.30–18.00

Coffee Break

 

18.00–19.20

Fascinating Failures and Surprising Successes-Case -
4 Case presentation sections (10 mins. Talk - 10 mins. Questions)

18.00–18.20
Post-partum dyspnea: Complexity of Acute Listing and Urgent Transplant in patients evaluated for Lung Transplant following cardiac arrest on ECMO

Göran Rådegran
Lund

18.20–18.40
The First DCD Heart in the Netherlands

Nils van der Kaay,
Groningen

18.40–19.00
Heart-Kidney Transplant from Durable LVAD and Centrimag RVAD Support

Clive Lewis,
Cambridge

19.00–19.20
Lung Transplantation following COVID-19 ARDS

Anders Andreasson,
Vienna

Thursday 20th January 2022

Focus on Long Term Problems in Cardiothoracic Transplantation

Moderator: Clive Lewis + young investigator.

16.00–16.20

Heart Transplantation: The Road Ahead

Hans Eiskjaer,
 Aarhus

16.20–16.40

Renal dysfunction post LVAD: measured GFR

Sven-Erik Bartfay,
 Gothenburg

16.40–17.00

Chronic Lung Allograft Dysfunction (CLAD)

Robin Vos,
Leuven

17.00–17.20

CLAD: The ScanCLAD Study

Göran Dellgren,
Gothenburg

17.20–17.40

Business Meeting

17.40–18.00

Coffee break

18.00–18.20

Cardiac Allograft Vasculopathy

Tor Clemmensen,
Aarhus

18.20–18.40

Advances in Immunosuppression

Erik Verschuuren,
Groningen

18.40–19.30

LVAD Therapy will be the New Standrard for most Patients with End Stage Heart Failure

Stephan Schueler
Newcastle

Friday 21st January 2022

Moderator: Göran Dellgren + one young investigator

(10-20 min talks and 10 min discussion)

16.00–16.20

Cardiothoracic Transplantation in the setting of COVID-19

Margaret Hannan,
Dublin

16.20–16.40

Torque Tenovirus monitoring in Heart Transplantation

Hans Eiskjaer,
Aarhus

16.40–17.00

High Risk Donors and Hepatitis C including feedback from ESHLT symposium

Margaret Hannan
Dublin

17.00–17.30

WERNER ZUBER MEMORIAL LECTURE

17.00–17.30
Ötzi, The Iceman

Prof Frank Rüehli,
Zurich

17.30–18.00

Coffee break

18.00–19.30

Young Investigators Abstract Presentations

(10 mins. Talk - 5 mins. Questions)

18.00–18.15
Normothermic regional perfusion of circulatory dead donor hearts: Optimal reperfusion time?

Niels Moeslund
Aarhus

18.15–18.30
Impact of COVID-19 lockdown on lung transplant recipients: decline in overall respiratory virus infections is associated with stabilization of lung function

Auke de Zwart
Groningen

18.30–18.45
Clinical Experience with The Cold Storage SherpaPakTM System for Donor Heart Transportation

Hassiba Smail
Harefield

18.45–19.00
Waiting list dynamics and lung transplant outcomes after introduction of the lung allocation score in the Netherlands

Thijs Hoffman
Nieuwegein

19.00–19.15
Clinical consequences of Immunosuppression after Heart Transplantation with reference to osteoporosis and renal function

Eveline Löfdahl
Lund

19.15–19.30
ESOT Transplant Fellowship: Clinical and Academic opportunities

Anders Andreasson
Vienna




Hep-C Donor Working Group

We are developing a morning workshop on Hepatitis C donors in cardiothoracic transplantation. If you are interested in attending the workshop please send a message to our administrative secretary Anne Lawless (annelawless@mater.ie).

List of potential participants.

Abbas Khushnood

Freeman Hospital, Newcastle UK

Anja Roden

Mayo Clinic, Rochester, USA

Anton Peleg

Alfred Hospital, Melbourne, Australia

Arne Jan Petersen

Riks Hospital, Oslo, Norway

Caroline Patterson

Royal Papworth Hospital, Cambridge, UK

Clive Lewis

Royal Papworth Hospital, Cambridge, UK

Diana van Kessel

University Centre, Utrecht, The Netherlands

Dieuwertje Ruigrok

UMC, Utrecht, The Netherlands

Erik Verschuuren

UMCG, Groningen, The Netherlands

Ethel Metz

UMCG, Groningen, The Netherlands

Gaia Viganó

Freeman Hospital, Newcastle, UK

Guillermo Rodriguez

Mater University Hospital, Dublin, Ireland

James Barnard

Manchester University, Hospital, UK

Jan van der Linden

Karolinska Institute, Stockholm, Sweden

Jim Egan

Mater University Hospital, Dublin, Ireland

Johanna Kwakkel-van Erp

UZA, Antwerp, Belgium

John Scott

Mayo Clinic, Rochester, USA

Lars Nolke

Mater University Hospital, Dublin, Ireland

Margaret Hannan

Mater University Hospital, Dublin, Ireland

Martin Goddard

Royal Papworth Hospital, Cambridge, UK

Martin Strueber

Beth Israel Medical Centre, NY, USA

Michael Perch

Rigs Hospital, Copenhagen, Denmark

Nicolaas de Jonge

University MC., Utrecht, The Netherlands

Pár-ola Larssan

XVIVO Perfusion AD, Goteborg, Sweden

Patrick Evrard

CHU, UCL, Godinne, Belgium

Patrick von Samson

University Hospital, Munich, Germany

Philipp Kaiser

General Hospital Vienna, Austria

Rachel Zabner

Cedars Sinai Medical Centre, CA, USA

Ronny Gustafsson

Lund University, Sweden

Selim Arcasoy

Columbia University, NY, USA

Stephanie Dunn

Freeman Hospital, Newcastle, UK

Stephen Schueler

Freeman Hospital, Newcastle, UK

Thomas Hartmann

Paragonix Technologies, Germany

Vanda Friman

Dept of Inf. Diseases, Gothenburg, Sweden

Yaron Barac

Rubin Medical Centre, Petah Tikva, Israel

Proudly Sponsored by